The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis.
Diabetologia
; 59(8): 1778-90, 2016 08.
Article
in En
| MEDLINE
| ID: mdl-27168137
Full text:
1
Database:
MEDLINE
Main subject:
Sulfonamides
/
Thiophenes
/
Receptor, Angiotensin, Type 2
/
Diabetes Mellitus, Experimental
/
Atherosclerosis
/
Angiotensin II Type 2 Receptor Blockers
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Year:
2016
Type:
Article